Ronald L. Drengler, M.D., Clinical Investigator – FDA Inspection, Apr 25, 2017

Record Details

This FDA Inspection record concerns Ronald L. Drengler, M.D., Clinical Investigator, with an inspection on April 25, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Ronald L. Drengler, M.D., Clinical Investigator
Inspection Date: April 25, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Joel Martinez (FDA Associated Person)

View Company Profile

ID · 84751261-ca3a-49c4-9b2e-b31a6acbd112

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1012031
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

FDA Citations

21 CFR 312.66Initial and continuing review

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ronald L. Drengler, M.D., Clinical Investigator

FDA Inspection

Ronald L. Drengler, M.D., Clinical InvestigatorApril 25, 2017